Effects of Ribavirin and dexamethasone on clinical outcome of Crimean-Congo Hemorrhagic Fever
Not Applicable
- Conditions
- Crimean-Congo Hemorrhagic Fever.Central Asian haemorrhagic fever
- Registration Number
- IRCT2015120525378N1
- Lead Sponsor
- Vice chancellor for research,Zahedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
severe thrombocytopenia (plt<20000); petechiae, ecchymosis or bleeding; low serum levels of fibrinogen (=120 mg/dl); ptt=60; Loss of consciousness
Exclusion criteria: no sever CCHF (base on SSI criteria); pregnancy; underlying disorder; receive Immunosuppressive drugs; Patients who do not have the necessary cooperation; All patients who received any antiviral , blood or blood products from the onset of symptoms to admission to Boo_Ali hospital; All patients who have not confirmed CCHF
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mortality rate. Timepoint: After intervention. Method of measurement: Based on the observed and recorded data.;Need of blood products. Timepoint: After Intervention. Method of measurement: According to transfused units.;Recovery rate. Timepoint: After intervention. Method of measurement: Based on the observed and recorded data.
- Secondary Outcome Measures
Name Time Method